Dietary fiber intervention on gut microbiota composition in healthy adults: A systematic review and meta-analysis

American Journal of Clinical Nutrition

Volumn 107, Issue 6, 2018, Pages 965-983

  So, Daniel ^a   Whelan, Kevin ^b   Rossi, Megan ^b   Morrison, Mark ^c   Holtmann, Gerald ^c,d   Kelly, Jaimon T ^a   Shanahan, Erin R ^c,d   Staudacher, Heidi M ^c   Campbell, Katrina L ^a,e  

^a BOND UNIVERSITY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d University of Queensland ^*  (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

diet; dietary fiber; gastrointestinal microbiome; gastrointestinal microbiota; gut microbiota; prebiotic

Indexed keywords

BUTYRIC ACID; FRUCTAN; GALACTOSE OLIGOSACCHARIDE; PLACEBO; PREBIOTIC AGENT; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM; CINAHL; CROSSING OVER; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; EMBASE; ENTERIC FEEDING; FECES; FECES MICROFLORA; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MEDLINE; META ANALYSIS; MICROBIAL DIVERSITY; MICROBIOLOGICAL EXAMINATION; POPULATION ABUNDANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; ADMINISTRATION AND DOSAGE; BACTERIUM; CLASSIFICATION; FOOD ANALYSIS;

ADULT; BACTERIA; DIETARY FIBER; FOOD ANALYSIS; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 85048669576     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.1093/ajcn/nqy041     Document Type: Article

References (128)

1. Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 2016;14:e1002533.
2. Marchesi JR, Adams DH, Fava F, Hermes GDA, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM et al. The gut microbiota and host health: a newclinical frontier.Gut 2016;65:330-9.
3. Scott KP, Duncan SH, Flint HJ. Dietary fibre and the gut microbiota. Nutr Bull 2008;33:201-11.
4. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, VenturaM. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 2013;24:160-8.
5. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-23.
6. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
7. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012;148:1258-70.
8. de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev 2012;70(Suppl 1):S45-56.
9. Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M, Vatanen T, Mujagic Z, Vila AV, Falony G, Vieira-Silva S et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (New York, NY) 2016;352:565-9.
10. Fraher MH, O'Toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol 2012;9:312-22.
11. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002;68:3401-7.
12. Lozupone CA, Knight R. Species divergence and the measurement of microbial diversity. FEMS Microbiol Rev 2008;32:557-78.
13. Morgan XC, Huttenhower C. Chapter 12: human microbiome analysis. PLoS Comput Biol 2012;8:e1002808.
14. Tojo R, Suarez A, Clemente MG, de los Reyes-Gavilan CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014;20:15163-76.
15. Bottacini F, Ventura M, van Sinderen D, O'Connell Motherway M. Diversity, ecology and intestinal function of bifidobacteria. Microbial Cell Factories 2014;13(Suppl 1):S4.
16. Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients 2011;3:118-34.
17. Satokari RM, Vaughan EE, Smidt H, Saarela M, Matto J, de Vos WM. Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst Appl Microbiol 2003;26:572-84.
18. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microbial Cell Factories 2011;10(Suppl 1):S17.
19. Flint HJ, Duncan SH, Louis P. The impact of nutrition on intestinal bacterial communities. Curr Opin Microbiol 2017;38:59-65.
20. Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc 2015;74:13-22.
21. Ze X, Duncan SH, Louis P, Flint HJ. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012;6:1535-43.
22. Ze X, Le Mougen F, Duncan SH, Louis P, Flint HJ. Some are more equal than others: the role of "keystone" species in the degradation of recalcitrant substrates. Gut Microbes 2013;4:236-40.
23. Scott KP, Antoine J-M, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 2015;26:25877.
24. O'Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 2016;13:691-706.
25. Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 2016;7:979.
26. FAO/WHO. CODEX Alimentarius (CODEX) Guidelines on Nutrition Labeling CAC/GL 2-1985. 2017. Available from: http://www.fao.org/fao-who-codexalimentarius/sh-proxy/es/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCAC%2BGL%2B2-1985%252FCXG-002e.pdf
27. Federalregister.gov [Internet]. Food labeling: revision of the nutrition and supplement facts labels (21 CFR 101) [Internet]. c.May 2016 [cited 2018 Jan 10].Washington (DC): Food and Drug Administration, Health and Human Services. Federal Register. Available from: https://www.federalregister.gov/documents/2016/05/27/2016-11867/foodlabelingrevision-of-the-nutrition-and-supplement-facts-labels.
28. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:718-27.
29. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 2017;8:172-84.
30. McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet 2017;117:251-64.
31. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-43.
32. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14:491-502.
33. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert- Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G et al. Dietary prebiotics: current status and new definition. Food Sci Technol Bull: Funct Foods 2010;7:1-19.
34. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010;104(Suppl 2):S1-63.
35. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-63.
36. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A et al. Dominant and dietresponsive groups of bacteria within the human colonic microbiota. ISME J 2011;5:220-30.
37. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knights D, WaltersWA, Knight R et al. Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, NY) 2011;334:105-8.
38. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. PNAS 2010;107:14691-6.
39. Schnorr SL, Candela M, Rampelli S, Centanni M, Consolandi C, Basaglia G, Turroni S, Biagi E, Peano C, Severgnini M et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014;5:3654.
40. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, Kurilshikov A, Bonder MJ, Valles-Colomer M, Vandeputte D et al. Population-level analysis of gut microbiome variation. Science (New York, NY) 2016;352:560-4.
41. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 2015;4:1-9.
42. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: Wiley, 2011.
43. Elmagarmid A, Fedorowicz Z, Hammady H, Ilyas I, Khabsa M, Ouzzani M. Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. In: Evidence-informed public health: opportunities and challenges. Abstracts of the 22nd Cochrane Colloquium. Hyderabad, India: John Wiley & Sons, 2014.
44. Higgins JPT, Deeks JJ, Altman DG. Special topics in statistics. In: Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons, 2008. p. 481-529.
45. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons, 2008. p. 187-241.
46. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons, 2008. p. 151-85.
47. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-9.
48. Sterne JAC, Egger M, Moher D. Addressing reporting biases. In: Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons, 2008. p. 297-333.
49. Hooda S, Vester Boler BM, Rossoni Serao MC, Brulc JM, Staeger MA, Boileau TW, Dowd SE, Fahey GC Jr, Swanson KS. 454 pyrosequencing reveals a shift in fecal microbiota of healthy adultmen consuming polydextrose or soluble corn fiber. J Nutr 2012;142:1259-65.
50. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009;101:541-50.
51. Vanegas SM, Meydani M, Barnett JB, Goldin B, Kane A, Rasmussen H, Brown C, Vangay P, Knights D, Jonnalagadda S et al. Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults. Am J Clin Nutr 2017;105:635-50.
52. Alles MS, Hartemink R, Meyboom S, Harryvan JL, Van Laere KMJ, Nagengast FM, Hautvast JGAJ. Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr 1999;69: 980-91.
53. Beards E, Tuohy K, Gibson G. A human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition. Br J Nutr 2010;104:701-8.
54. Bouhnik Y, Flourié B, Riottot M, Bisetti N, Gailing MF, Guibert A, Bornet F, Rambaud JC. Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr Cancer 1996;26:21-9.
55. Bouhnik Y, Raskine L, Champion K, Andrieux C, Penven S, Jacobs H, Simoneau G. Prolonged administration of low-dose inulin stimulates the growth of bifidobacteria in humans. Nutr Res 2007;27: 187-93.
56. Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J 2006;5:8.
57. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourié B, Brouns F, Bornet FR. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a doubleblind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80:1658-64.
58. Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourié B, Bornet F, Rambaud JC. Short-chain fructooligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 1999;129:113-16.
59. Brahe L, Chatelier E, Prifti E, Pons N, Kennedy S, Blædel T, Hakansson J, Dalsgaard T, Hansen T, Pedersen O et al. Dietary modulation of the gut microbiota -a randomised controlled trial in obese postmenopausal women. Br J Nutr 2015;114:406-17.
60. Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br J Nutr 2008;100:1269-75.
61. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PGB, Neyrinck AM, Bindels LB, De Vos WM, Gibson GR, Thissen JP et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013;62:1112-21.
62. Elison E, Vigsnaes LK, Rindom Krogsgaard L, Rasmussen J, Sørensen N, McConnell B, Hennet T, Sommer MOA, Bytzer P. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto- N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr 2016;116:1356-68.
63. Fastinger ND, Karr-Lilienthal LK, Spears JK, Swanson KS, Zinn KE, Nava GM, Ohkuma K, Kanahori S, Gordon DT, Fahey GC Jr. A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans. J Am Coll Nutr 2008;27:356-66.
64. Finegold S, Li Z, Summanen P, Downes J, Thames G, Corbett K, Dowd S, Krak M, Heber D. Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food Funct 2014;5:436-45.
65. Gopal PK, Prasad J, Gill HS. Effects of the consumption of Bifidobacterium lactis HN019 (DR10TM) and galactooligosaccharides on the microflora of the gastrointestinal tract in human subjects. Nutr Res 2003;23:1313-28.
66. Jie Z, Bang-Yao L, Ming-Jie X, Hai-Wei L, Zu-Kang Z, Ting-Song W, Craig S. Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Am J Clin Nutr 2000;72:1503-9.
67. Kleessen B, Schwarz S, Boehm A, Fuhrmann H, Richter A, Henle T, KruegerM. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 2007;98:540-9.
68. Lecerf JM, Dépeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H et al. Xylooligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 2012;108:1847-58.
69. Lin SH, Chou LM, Chien YW, Chang JS, Lin CI. Prebiotic effects of xylooligosaccharides on the improvement of microbiota balance in human subjects. Gastroenterol Res Pract 2016;2016:5789232.
70. Lomax AR, Cheung LVY, Tuohy KM, Noakes PS, Miles EA, Calder PC. β2-1 fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. Br J Nutr 2012;108:1818-28.
71. Nemoto H, Ikata K, Arimochi H, Iwasaki T, Ohnishi Y, Kuwahara T, Kataoka K. Effects of fermented brown rice on the intestinal environments in healthy adult. J Med Invest 2011;58:235-45.
72. Pallav K, Dowd SE, Villafuerte J, Yang X, Kabbani T, Hansen J, DennisM, Leffler DA, Kelly CP. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial. Gut Microbes 2014;5:458-67.
73. Pasman W, Wils D, Saniez MH, Kardinaal A. Long-term gastrointestinal tolerance of NUTRIOSE®FB in healthy men. Eur J Clin Nutr 2006;60:1024-34.
74. Ramnani P, Gaudier E, Bingham M, Van Bruggen P, Tuohy KM, Gibson GR. Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr 2010;104:233-40.
75. Tap J, Furet JP, Bensaada M, Philippe C, Roth H, Rabot S, Lakhdari O, Lombard V, Henrissat B, Corthier G et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol 2015;17:4954-64.
76. Wu WT, Cheng HC, Chen HL. Ameliorative effects of konjac glucomannan on human faecal beta-glucuronidase activity, secondary bile acid levels and faecal water toxicity towards Caco-2 cells. Br J Nutr 2011;105:593-600.
77. Alfa MJ, Strang D, Tappia PS, Graham M, Van Domselaar G, Forbes JD, Laminman V, Olson N, DeGagne P, Bray D et al. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults. Clin Nutr 2018;37:797-807.
78. Cooper DN, Kable ME, Marco ML, De Leon A, Rust B, Baker JE, Horn W, Burnett D, Keim NL. The effects of moderate whole grain consumption on fasting glucose and lipids, gastrointestinal symptoms, and microbiota. Nutrients 2017;9:173.
79. Karl JP, Meydani M, Barnett JB, Vanegas SM, Goldin B, Kane A, Rasmussen H, Saltzman E, Vangay P, Knights D et al. Substituting whole grains for refined grains in a 6-wk randomized trial favorably affects energy-balance metrics in healthy men and postmenopausal women. Am J Clin Nutr 2017;105:589-99.
80. Salden BN, Troost FJ, Wilms E, Truchado P, Vilchez-Vargas R, Pieper DH, Jáuregui R, Marzorati M, van de Wiele T, Possemiers S et al. Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: a randomized controlled trial. Arabinoxylans in gut barrier. Clin Nutr 2018;37:471-80.
81. Abell GCJ, Cooke CM, Bennett CN, Conlon MA, McOrist AL. Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol 2008;66:505-15.
82. Ampatzoglou A, Atwal KK, Maidens CM, Williams CL, Ross AB, Thielecke F, Jonnalagadda SS, Kennedy OB, Yaqoob P. Increased whole grain consumption does not affect blood biochemistry, body composition, or gut microbiology in healthy, low-habitual whole grain consumers. J Nutr 2015;145:215-21.
83. Baer DJ, Stote KS, Henderson T, Paul DR, Okuma K, Tagami H, Kanahori S, Gordon DT, Rumpler WV, Ukhanova M et al. The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men. J Nutr 2014;144:1023-9.
84. Boler B, Serao M, Bauer L, Staeger M, Boileau T, Swanson K, Fahey G. Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr 2011;106:1864-71.
85. Carvalho-Wells AL, Helmolz K, Nodet C, Molzer C, Leonard C, McKevith B, Thielecke F, Jackson KG, Tuohy KM. Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study. Br J Nutr 2010;104: 1353-6.
86. Clarke S, Green-Johnson J, Brooks S, Ramdath D, Bercik P, Avila C, Inglis G, Green J, Yanke L, Selinger L et al. beta2-1 fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults. Br J Nutr 2016;115:1748-59.
87. Cloetens L, Broekaert WF, Delaedt Y, Ollevier F, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K. Tolerance of arabinoxylanoligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study. Br J Nutr 2010;103:703-13.
88. Costabile A, Fava F, Röytiö H, Forssten SD, Olli K, Klievink J, Rowland IR, Ouwehand AC, Rastall RA, Gibson GR et al. Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr 2012;108:471-81.
89. Costabile A, Klinder A, Fava F, Napolitano A, Fogliano V, Leonard C, Gibson GR, Tuohy KM. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebocontrolled, crossover study. Br J Nutr 2008;99:110-20.
90. Costabile A, Kolida S, Klinder A, Gietl E, Buerlein M, Frohberg C, Landschütze V, Gibson GR. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 2010;104:1007-17.
91. Damen B, Cloetens L, Broekaert WF, François I, Lescroart O, Trogh I, Arnaut F, Welling GW, Wijffels J, Delcour JA et al. Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers. J Nutr 2012;142:470-7.
92. Depeint F, Tzortzis G, Vulevic J, I'Anson K, Gibson GR. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr 2008;87: 785-91.
93. Fernando W, Hill J, Zello G, Tyler R, Dahl W, Kessel A. Diets supplemented with chickpea or its main oligosaccharide component raffinosemodify faecal microbial composition in healthy adults. Benef Microbes 2010;1:197-207.
94. François IEJA, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, Hamer H, Houben E, Windey K, Welling GW et al. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial. Br J Nutr 2012;108:2229-42.
95. Fuller Z, Louis P, Mihajlovski A, Rungapamestry V, Ratcliffe B, Duncan AJ. Influence of cabbage processing methods and prebiotic manipulation of colonic microflora on glucosinolate breakdown in man. Br J Nutr 2007;98:364-72.
96. Grasten SM, Juntunen KS, Mättö J, Mykkänen OT, El-Nezami H, Adlercreutz H, Poutanen KS, Mykkänen HM. High-fiber rye bread improves bowel function in postmenopausalwomen but does not cause other putatively positive changes in the metabolic activity of intestinal microbiota. Nutr Res 2007;27:454-61.
97. Holscher HD, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS. Agave inulin supplementation affects the fecal microbiota of healthy adults participating in a randomized, doubleblind, placebo-controlled, crossover trial. J Nutr 2015;145:2025-32.
98. Jenkins DJA, Vuksan V, Rao AV, Vidgen E, Kendall CWC, Tariq N, Würsch P, Koellreutter B, Shiwnarain N, Jeffcoat R. Colonic bacterial activity and serum lipid risk factors for cardiovascular disease. Metabolism 1999;48:264-8.
99. Maki KC, Gibson GR, Dickmann RS, Kendall CWC, Chen CYO, Costabile A, Comelli EM, McKay DL, Almeida NG, Jenkins D et al. Digestive and physiologic effects of a wheat bran extract, arabinoxylan- oligosaccharide, in breakfast cereal. Nutrition 2012;28:1115-21.
100. Maneerat S, Lehtinen MJ, Childs CE, Forssten SD, Alhoniemi E, Tiphaine M, Yaqoob P, Ouwehand AC, Rastall RA. Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes. J Nutr Sci 2013;2:e44.
101. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010;5:e15046.
102. Petry N, Egli I, Chassard C, Lacroix C, Hurrell R. Inulin modifies the bifidobacteria population, fecal lactate concentration, and fecal pH but does not influence iron absorption in women with low iron status. Am J Clin Nutr 2012;96:325-31.
103. Ramnani P, Costabile A, Bustillo AGR, Gibson GR. A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. J Nutr Sci 2015;4:e10.
104. Ross AB, Bruce SJ, Blondel-Lubrano A, Oguey-Araymon S, Beaumont M, Bourgeois A, Nielsen-Moennoz C, Vigo M, Fay LB, Kochhar S et al. A whole-grain cereal-rich diet increases plasma betaine, and tends to decrease total and LDL-cholesterol compared with a refined-grain diet in healthy subjects. Br J Nutr 2011;105:1492-502.
105. Slavin J, Feirtag J. Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct 2011;2:72-7.
106. Smith SC, Choy R, Johnson SK, Hall RS, Wildeboer-Veloo ACM, Welling GW. Lupin kernel fiber consumption modifies fecal microbiota in healthy men as determined by rRNA gene fluorescent in situ hybridization. Eur J Nutr 2006;45:335-41.
107. Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, Van Der Meer R. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. J Nutr 2006;136:70-4.
108. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructooligosaccharides - A human volunteer study. Br J Nutr 2001;86: 341-8.
109. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 2008;88: 1438-46.
110. Vulevic J, Juric A, Walton GE, Claus SP, Tzortzis G, Toward RE, Gibson GR. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br J Nutr 2015;114:586-95.
111. Walton G, Heuvel E, Kosters M, Rastall R, Tuohy K, Gibson G. A randomised crossover study investigating the effects of galactooligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 2012;107:1466-75.
112. Walton GE, Lu C, Trogh I, Arnaut F, Gibson GR. A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylanoligosaccharides enriched bread in healthy volunteers. Nutr J 2012;11:36.
113. Walton GE, Rastall RA, Rastall RA, Martini MC, Williams CE, Jeffries RL, Gibson GR. A double-blind, placebo controlled human study investigating the effects of coffee derived mannooligosaccharides on the faecal microbiota of a healthy adult population. Int J Probiotics Prebiotics 2010;5:75-83.
114. Zeng Y, Huang S, Mu G, Zeng X, Zhou X. Effects of whole grain-bean mixed staple food on intestinal microecology and metabolic parameters of obese people. Chinese J Clin Nutr 2015;23: 27-34.
115. Blædel T, Holm JB, Sundekilde UK, Schmedes MS, Hess AL, Lorenzen JK, Kristiansen K, Dalsgaard TK, Astrup A, Larsen LH. A randomised, controlled, crossover study of the effect of diet on angiopoietin-like protein 4 (ANGPTL4) through modification of the gut microbiome. J Nutr Sci 2016;5:e45.
116. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O'Sullivan O et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84.
117. Coyte KZ, Schluter J, Foster KR. The ecology of the microbiome: networks, competition, and stability. Science (New York, NY) 2015;350:663-6.
118. Johnson KVA, Burnet PWJ. Microbiome: should we diversify from diversity? Gut Microbes 2016;7:455-8.
119. Van der Meulen R, Adriany T, Verbrugghe K, De Vuyst L. Kinetic analysis of bifidobacterial metabolism reveals aminor role for succinic acid in the regeneration of NAD+ through its growth-associated production. Appl Environ Microbiol 2006;72:5204-10.
120. Ganzle MG, Follador R. Metabolism of oligosaccharides and starch in lactobacilli: a review. Front Microbiol 2012;3:340.
121. Gueimonde M, Debor L, Tolkko S, Jokisalo E, Salminen S. Quantitative assessment of faecal bifidobacterial populations by realtime PCR using lanthanide probes. J Appl Microbiol 2007;102:1116-22.
122. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R. Development of 16S rRNA-genetargeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002;68:5445-51.
123. Davis LMG, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011;6:e25200.
124. Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 2005;135:1896-902.
125. Moreno-Indias I, Sanchez-Alcoholado L, Perez-Martinez P, Andres- Lacueva C, Cardona F, Tinahones F, Queipo-Ortuno MI. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. Food Funct 2016;7:1775-87.
126. Pokusaeva K, Fitzgerald GF, van Sinderen D. Carbohydrate metabolism in Bifidobacteria. Genes Nutr 2011;6:285-306.
127. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011;17:1519-28.
128. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013;54:2325-40.